Oct 8, 2026 08:00AM
Oct 7, 2026 08:31AM
Oct 7, 2026 08:31AM
Sep 30, 2026 04:01PM
Sep 30, 2026 04:01PM
Sep 29, 2026 08:00AM
Sep 29, 2026 08:00AM Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering
Sep 26, 2026 10:28AM
Sep 23, 2026 07:45AM
Sep 22, 2026 07:45AM
Sep 22, 2026 07:45AM
Sep 17, 2026 08:20AM
Aug 14, 2026 07:30AM
Aug 8, 2026 12:00PM New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results
Aug 7, 2026 08:00AM
Aug 3, 2026 07:31AM
Aug 3, 2026 07:30AM
Jul 28, 2026 07:45AM
Jul 28, 2026 07:45AM
Jul 23, 2026 08:01AM
Jul 23, 2026 08:01AM Lantern Pharma Receives USPTO Notice of Allowance for Patent Covering Biomarker-Guided Treatment with LP-184 (Zirdafulven) in Multiple Solid Tumor Cancers
Jul 8, 2026 07:30AM
Jul 8, 2026 07:30AM
Jun 2, 2026 08:15AM
Jun 2, 2026 08:13AM
May 19, 2026 07:30AM
May 19, 2026 07:30AM
May 15, 2026 04:01PM Lantern Pharma Reports First Quarter 2026 Financial Results and Provides Business Updates
May 14, 2026 04:05PM
May 14, 2026 04:05PM
May 14, 2026 04:05PM
May 13, 2026 08:00AM
May 13, 2026 08:00AM
May 11, 2026 04:30PM
May 7, 2026 09:01AM Lantern Pharma announces roadmap for withZeta.ai AI platform expansion
May 7, 2026 09:01AM
Apr 29, 2026 08:50AM
Apr 24, 2026 07:50AM
Apr 20, 2026 08:05AM
Apr 20, 2026 08:05AM
Apr 14, 2026 08:36AM
Apr 14, 2026 08:31AM Lantern Pharma Launches withZeta.ai — the World’s First Multi-Agentic A.I. Co-Scientist for Rare Cancer Drug Discovery & Development — Subscriptions Now Open; Debut Events at Nasdaq MarketSi
Apr 2, 2026 08:10AM
Mar 30, 2026 04:05PM
Mar 27, 2026 07:29AM
Mar 27, 2026 07:29AM
Mar 23, 2026 04:30PM
Feb 10, 2026 08:45AM
Jan 20, 2026 08:04AM Lantern Pharma's LP-284 gets FDA orphan drug status for soft tissue sarcoma
Jan 20, 2026 08:00AM

334,274 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All